Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Murat Beyzadeoglu, Gokhan Ozyigit, Ugur Selek.
    Contents:
    Radiation Physics
    Radiobiology
    Clinical Radiation Oncology
    Central Nervous System Tumors
    Head and Neck Cancers
    Lung Cancer
    Breast Cancer
    Genitourinary System Cancers
    Gynecological Cancers
    Gastrointestinal System Cancers
    Soft Tissue Sarcoma
    Skin Cancer
    Lymphomas and Total Body Irradiation
    Pediatric Tumors
    Rare Tumors and Benign Diseases.
    Digital Access Springer 2012
  • Article
    Weitzman SA, Aisenberg AC, Siber GR, Smith DH.
    N Engl J Med. 1977 Aug 04;297(5):245-8.
    To define the contribution of aggressive lymphoma treatment to the risk of post-splenectomy septicemia, we investigated the humoral immunity of 44 patients with Hodgkin's disease. Specific antibody against Haemophilus influenzae Type b was significantly reduced (mean, 147 ng per milliliter, P less than 0.01) in patients receiving combined treatment (radiotherapy and chemotherapy), whereas single treatment reduced titers marginally (chemotherapy) or not at all (radiotherapy). Untreated patients had normal values (396 ng per milliliter), and splenectomy was without effect. In some patients who received combined treatment, titers were reduced to levels seen in infants. IgM levels were likewise normal in untreated patients. Chemotherapy, however, significantly reduced IgM levels (P less than 0.025), an effect potentiated by prior splenectomy. IgG, IgA, alternate-pathway activity, C3, C4 and CH50 were all normal or elevated. Aggressive treatment with chemotherapy and radiation impairs humoral defense against encapsulated micro-organisms, and thus magnifies the risk of post-splenectomy septicemia in patients with Hodgkin's disease.
    Digital Access Access Options